These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 497336)

  • 21. Heart failure and sudden death in dilated cardiomyopathy: a hidden competition we should not forget about when modelling mortality.
    Gregori D; Rosato R; Zecchin M; Baldi I; Di Lenarda A
    J Eval Clin Pract; 2008 Feb; 14(1):53-8. PubMed ID: 18211644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks data.
    Ng SK; McLachlan GJ
    Stat Med; 2003 Apr; 22(7):1097-111. PubMed ID: 12652556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression models for infant mortality data in Norwegian siblings, using a compound Poisson frailty distribution with random scale.
    Moger TA; Aalen OO
    Biostatistics; 2008 Jul; 9(3):577-91. PubMed ID: 18304994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some interrelationships among the regression coefficient estimates arising in a class of models appropriate to response-time data.
    Byar DP; Mantel N
    Biometrics; 1975 Dec; 31(4):943-7. PubMed ID: 1203434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression modeling of semicompeting risks data.
    Peng L; Fine JP
    Biometrics; 2007 Mar; 63(1):96-108. PubMed ID: 17447934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models.
    Fiocco M; Putter H; van Houwelingen HC
    Stat Med; 2008 Sep; 27(21):4340-58. PubMed ID: 18425994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing alternative models: log vs Cox proportional hazard?
    Basu A; Manning WG; Mullahy J
    Health Econ; 2004 Aug; 13(8):749-65. PubMed ID: 15322988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure-time-varying hazard function ratios in case-control studies of drug effects.
    Guess HA
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):81-92. PubMed ID: 16287211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating cardiovascular mortality in type 2 diabetes patients: an analysis based on competing risks Markov chains and additive regression models.
    Rosato R; Ciccone G; Bo S; Pagano GF; Merletti F; Gregori D
    J Eval Clin Pract; 2007 Jun; 13(3):422-8. PubMed ID: 17518809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hazard function and life table: an introduction to the failure time analysis.
    Matsushita K; Inaba H
    Jinko Mondai Kenkyu; 1987 Apr; (182):36-50. PubMed ID: 12314929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attributable risk function in the proportional hazards model for censored time-to-event.
    Chen YQ; Hu C; Wang Y
    Biostatistics; 2006 Oct; 7(4):515-29. PubMed ID: 16478758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some diagnostic methods for Cox regression models through hazard smoothing.
    Gray RJ
    Biometrics; 1990 Mar; 46(1):93-102. PubMed ID: 2190638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.
    Goodman AC; Hankin JR; Kalist DE; Peng Y; Spurr SJ
    J Ment Health Policy Econ; 2001 Jun; 4(2):65-77. PubMed ID: 11967467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On robustness and model flexibility in survival analysis: transformed hazard models and average effects.
    Gustafson P
    Biometrics; 2007 Mar; 63(1):69-77. PubMed ID: 17447931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of cumulative incidence function under the proportional hazards model.
    Cheng SC; Fine JP; Wei LJ
    Biometrics; 1998 Mar; 54(1):219-28. PubMed ID: 9544517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial neural network for the joint modelling of discrete cause-specific hazards.
    Biganzoli EM; Boracchi P; Ambrogi F; Marubini E
    Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a contract breeding management program in selected Ohio dairy herds with event-time analysis I. Cox proportional hazards models.
    Meadows C; Rajala-Schultz PJ; Frazer GS; Meiring RW; Hoblet KH
    Prev Vet Med; 2006 Dec; 77(3-4):145-60. PubMed ID: 16887223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.